In patients with pelvic endometriosis, secondary symptoms were smaller and better tolerated with nafarelin than with goserelin.
In plain wordsIn patients with pelvic endometriosis, secondary symptoms were milder and better tolerated with nafarelin than with goserelin.
- Peptide
- Nafarelin
- Outcome
- DecreaseSecondary symptoms
- Study
n = 15
- Comparator
- goserelin acetate
- Outcome group
- Adverse events · Reproductive and sexual health
- Studied dose
- 200 or 400 micrograms each 12 hoursAs given in this study (human).
Source sentences
The secondary symptoms are smaller and better supported by the patients using nafarelin.
1 context sentence(design, population, supporting numbers)
15 patients were studied in who the diagnosis settled down of endometriosis by means of laparoscope; these were formed two groups in aleatory form